New Arrival China C Diff Vancomycin Treatment - D-Amino Acids Series for Solid Phase Synthesis – Gentolex
New Arrival China C Diff Vancomycin Treatment - D-Amino Acids Series for Solid Phase Synthesis – Gentolex Detail:
Product Detail
|
No |
Products |
CAS No. |
Key quality indicator |
||||
|
Purity |
Isomer |
Specific Impurity |
*Max1 |
Moisture |
|||
|
1 |
Fmoc-D-Ala-OH.H2O | 79990-15-1 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤6.5% |
|
2 |
Fmoc-3-(2-naphthyl)-D-Ala-OH | 138774-94-4 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
3 |
Ac-3-(2-naphthyl)-D-Ala-OH | 37440-01-0 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
4 |
Fmoc-3-(3-pyridinyl)-D-Ala-OH | 142994-45-4 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
5 |
Fmoc-D-Aph(tBuCbm)-OH | 1433975-21-3 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
6 |
Fmoc-D-Aph(Cbm)-OH | 324017-22-3 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
7 |
Fmoc-D-Aph(Hor)-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
8 |
Fmoc-Aph(D-Hor)-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
9 |
Fmoc-D-Arg(pbf)-OH | 187618-60-6 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
10 |
Fmoc-D-Arg (NO2)-OH | 160347-94-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
11 |
Fmoc-D-HomoArg(pbf)-OH | 401915-53-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
12 |
Fmoc-D-HomoArg(Et)2-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
13 |
Fmoc-D-Asn(Trt)-OH | 180570-71-2 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
14 |
Fmoc-D-Asp(OtBu)-OH | 112883-39-3 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
15 |
Fmoc-D-Asp-OtBu | 34098-70-7 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
16 |
Fmoc-D-Asp(OAll)-OH | 177609-12-0 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
17 |
Fmoc-D-Cit-OH | 200344-33-8 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
18 |
Fmoc-D-Cys(Trt)-OH | 167015-11-4 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
19 |
Fmoc-D-Cys(Acm)-OH | 168300-88-7 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
20 |
Fmoc-D-Cys(Mmt)-OH | 1198791-73-9 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
21 |
Fmoc-D-Gln(Trt)-OH | 200623-62-7 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
22 |
Fmoc-D-Glu(OtBu)-OH.H2O | 104091-08-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤5.0% |
|
23 |
Fmoc-D-Glu-OtBu | 109745-15-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
24 |
H-D-Glu-OtBu | 25456-76-2 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
25 |
Fmoc-D-His(Trt)-OH | 135610-90-1 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
26 |
Boc-D-His(Trt)-OH | 393568-74-6 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
27 |
Fmoc-D-His(Bzl)-OH | 1417638-37-9 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
28 |
Fmoc-D-Ile-OH | 143688-83-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
29 |
Fmoc-D-Allo-Ile-OH | 118904-37-3 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
30 |
Fmoc-D-Leu-OH | 114360-54-2 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
31 |
Fmoc-D-Lys(Boc)-OH | 92122-45-7 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
32 |
Fmoc-D-Lys(Alloc)-OH | 214750-75-1 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
33 |
Fmoc-D-Lys(ivDde)-OH | 1272755-33-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
34 |
Fmoc-D-Lys(Mmt)-OH | 198544-94-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
35 |
Fmoc-D-Lys(iPr,Boc)-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
36 |
Fmoc-D-Lys(nicotinoyl)-OH | 252049-12-0 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
37 |
Fmoc-D-Met-OH | 112883-40-6 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
38 |
Fmoc-D-Orn(Boc)-OH | 118476-89-4 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
39 |
Fmoc-D-Phe-OH | 86123-10-6 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
40 |
Fmoc-4-chloro-D-Phe-OH | 142994-19-2 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
41 |
Fmoc-D-Pro-OH.H2O | 101555-62-8 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤6.0% |
|
42 |
D-Pyr-OH | 4042-36-8 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
43 |
Fmoc-D-Ser(tBu)-OH | 128107-47-1 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
44 |
Fmoc-D-Ser(Trt)-OH | 212688-51-2 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
45 |
Fmoc-D-Thr(tBu)-OH | 138797-71-4 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
46 |
Fmoc-D-Trp(Boc)-OH | 163619-04-3 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
47 |
Fmoc-2-methyl-D-Trp-OH | 196808-79-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
48 |
Fmoc-D-Tyr(tBu)-OH | 118488-18-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
49 |
Fmoc-D-Tyr(Et)-OH | 162502-65-0 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
50 |
Fmoc-D-Tyr(Me)-OH | 201335-88-8 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
51 |
Fmoc-N-Me-D-Tyr(tBu)-OH | 196808-79-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
52 |
Fmoc-D-Tyr (Bzl)-OH | 138775-48-1 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
53 |
Fmoc-D-Val-OH | 84624-17-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
54 |
Fmoc-D-Hyp(tBu)-OH | 464193-92-8 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
55 |
Fmoc-D-Thi-OH | 201532-42-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
56 |
Fmoc-D-Tic-OH | 130309-33-0 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
57 |
Fmoc-D-Oic-OH | 130309-37-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
58 |
Boc-D-His(Trt)-Aib-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
59 |
Fmoc-D-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
60 |
Boc-D-His(Trt)-Aib-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
61 |
Boc-His(Trt)-Aib-D-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
62 |
Boc-D-His(Trt)-Aib-D-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
63 |
Fmoc-D-Arg(pbf)-Gly-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
64 |
Fmoc-D-Ala-Ala-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
65 |
Fmoc-Ala-D-Ala-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
66 |
Fmoc-D-Ala-D-Ala-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
67 |
Fmoc-D-Lys(Palm-Glu-OtBu)-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
68 |
Fmoc-Lys(Palm-D-Glu-OtBu)-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
69 |
Fmoc-D-Lys(Palm-D-Glu-OtBu)-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
70 |
Octa(OtBu)-D-Glu-OtBu | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
71 |
Octa(OtBu)-D-Glu(ɑ-OtBu)-AEEA-AEEA-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
*Max1 = Max Unknown Purity
Other Info:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
Purified Water
Purified water is used in production and equipment cleaning for API. Purified water is generated by city water, processed through pre-treatment (multi-media filter, softener, activated carbon filter, etc.) and reverse osmosis (RO), and then the purified water is stored in the tank. The water is constantly circulating at 25±2℃ with flow rate of 1.2m/s.
Product detail pictures:
Related Product Guide:
Our company insists all along the quality policy of "product quality is base of enterprise survival; customer satisfaction is the staring point and ending of an enterprise; persistent improvement is eternal pursuit of staff" and the consistent purpose of "reputation first, customer first" for New Arrival China C Diff Vancomycin Treatment - D-Amino Acids Series for Solid Phase Synthesis – Gentolex , The product will supply to all over the world, such as: kazan, Holland, Casablanca, We have more than 8 years of experience in this industry and have a good reputation in this field. Our products have won praise from customers worldwide. Our aim is to help customers realize their goals. We are making great efforts to achieve this win-win situation and sincerely welcome you to join us.
By Dora from Chile - 2018.08.12 12:27
It can be said that this is a best producer we encountered in China in this industry, we feel lucky to work with so excellent manufacturer.
By Klemen Hrovat from Madras - 2018.02.21 12:14
